An example is the significant worse overall survival of patients with a grade II glioma with an IDH-wildtype tumor with gain of chromosome 7 and loss of chromosome 10 or with TERT mutations compared to those with an IDH-wildtype tumor without these lesions [1, 13, 16, 18, 21]. This evidence concerns the gene IDH1 and central nervous system cancer.